万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 技术资料
- 库存:
20
- 英文名:
cRGD-PEG-COOH,Mw 5k
- CAS号:
N/A
- 保质期:
参考随货COA
- 供应商:
赛可锐生物
- 保存条件:
参考随货COA
- 规格:
1mg
更多其他产品(药物杂质、食品检测标品、农兽残检测标品、环境及工业检测标品标液、维生素、胆汁酸、氨基酸、糖代谢、类花生酸、肉碱、脂肪酸、植物激素、动物激素、儿茶酚胺、植物提取物、修饰性peg、微球、分子生化、细胞、蛋白抗体)
| RGD PEG | ||
| SCPP-202875 | 整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-羧基,分子量5k | cRGD-PEG-COOH,Mw 5k |
| SCPP-202874 | 整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-羧基,分子量3.4k | cRGD-PEG-COOH,Mw 3.4k |
| SCPP-202873 | 整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-羧基,分子量2k | cRGD-PEG-COOH,Mw 2k |
| SCPP-202875 | 整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-羧基,分子量5k | RGD-PEG-COOH,Mw 5k |
| SCPP-202874 | 整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-羧基,分子量3.4k | RGD-PEG-COOH,Mw 3.4k |
| SCPP-202873 | 整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-羧基,分子量2k | RGD-PEG-COOH,Mw 2k |
| SCPP-205119 | 环肽cRGD-聚乙二醇-g-聚乙烯亚胺 | cRGD-PEG-PEI |
| SCPP-205120 | 整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-羟基,分子量5k | RGD-PEG-OH,Mw 5k |
| SCPP-205121 | 整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-羟基,分子量3.4k | RGD-PEG-OH,Mw 3.4k |
| SCPP-205122 | 整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-羟基,分子量2k | RGD-PEG-OH,Mw 2k |
| SCPP-202400 | 整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-巯基,分子量600 | iRGD-PEG-SH,Mw 600 |
| SCPP-202399 | 整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-巯基,分子量5k | iRGD-PEG-SH,Mw 5k |
| SCPP-202398 | 整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-巯基,分子量400 | iRGD-PEG-SH,Mw 400 |
| SCPP-202397 | 整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-巯基,分子量3.4k | iRGD-PEG-SH,Mw 3.4k |
| SCPP-202396 | 整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-巯基,分子量2k | iRGD-PEG-SH,Mw 2k |
| SCPP-202395 | 整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-巯基,分子量10k | iRGD-PEG-SH,Mw 10k |
| SCPP-202394 | 整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-巯基,分子量1k | iRGD-PEG-SH,Mw 1k |
| SCPP-202393 | 整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-叠氮,分子量5k | iRGD-PEG-N3,Mw 5k |
| SCPP-202392 | 整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-叠氮,分子量3.4k | iRGD-PEG-N3,Mw 3.4k |
| SCPP-202391 | 整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-叠氮,分子量2k | iRGD-PEG-N3,Mw 2k |
| SCPP-202390 | 整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-叠氮,分子量10k | iRGD-PEG-N3,Mw 10k |
| SCPP-202389 | 整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-叠氮,分子量1k | iRGD-PEG-N3,Mw 1k |
| SCPP-202388 | 整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-马来酰亚胺,分子量5k | iRGD-PEG-MAL,Mw 5k |
| SCPP-202387 | 整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-马来酰亚胺,分子量3.4k | iRGD-PEG-MAL,Mw 3.4k |
| SCPP-202386 | 整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-马来酰亚胺,分子量2k | iRGD-PEG-MAL,Mw 2k |
| SCPP-202400 | 整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-巯基,分子量600 | cRGD-PEG-SH,Mw 600 |
| SCPP-202399 | 整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-巯基,分子量5k | cRGD-PEG-SH,Mw 5k |
| SCPP-202398 | 整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-巯基,分子量400 | cRGD-PEG-SH,Mw 400 |
| SCPP-202397 | 整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-巯基,分子量3.4k | cRGD-PEG-SH,Mw 3.4k |
| SCPP-202396 | 整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-巯基,分子量2k | cRGD-PEG-SH,Mw 2k |
| SCPP-202395 | 整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-巯基,分子量10k | cRGD-PEG-SH,Mw 10k |
| SCPP-202394 | 整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-巯基,分子量1k | cRGD-PEG-SH,Mw 1k |
| SCPP-202393 | 整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-叠氮,分子量5k | cRGD-PEG-N3,Mw 5k |
| SCPP-202392 | 整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-叠氮,分子量3.4k | cRGD-PEG-N3,Mw 3.4k |
| SCPP-202391 | 整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-叠氮,分子量2k | cRGD-PEG-N3,Mw 2k |
| SCPP-202390 | 整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-叠氮,分子量10k | cRGD-PEG-N3,Mw 10k |
| SCPP-202389 | 整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-叠氮,分子量1k | cRGD-PEG-N3,Mw 1k |
| SCPP-202367 | 整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-氨基,分子量5k | cRGD-PEG-NH2,Mw 5k |
| SCPP-202366 | 整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-氨基,分子量3.4k | cRGD-PEG-NH2,Mw 3.4k |
| SCPP-202365 | 整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-氨基,分子量2k | cRGD-PEG-NH2,Mw 2k |
| SCPP-202400 | 整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-巯基,分子量600 | RGD-PEG-SH,Mw 600 |
| SCPP-202399 | 整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-巯基,分子量5k | RGD-PEG-SH,Mw 5k |
| SCPP-202398 | 整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-巯基,分子量400 | RGD-PEG-SH,Mw 400 |
| SCPP-202397 | 整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-巯基,分子量3.4k | RGD-PEG-SH,Mw 3.4k |
| SCPP-202396 | 整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-巯基,分子量2k | RGD-PEG-SH,Mw 2k |
| SCPP-202395 | 整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-巯基,分子量10k | RGD-PEG-SH,Mw 10k |
| SCPP-202394 | 整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-巯基,分子量1k | RGD-PEG-SH,Mw 1k |
| SCPP-202388 | 整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-马来酰亚胺,分子量5k | RGD-PEG-MAL,Mw 5k |
| SCPP-202387 | 整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-马来酰亚胺,分子量3.4k | RGD-PEG-MAL,Mw 3.4k |
| SCPP-202386 | 整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-马来酰亚胺,分子量2k | RGD-PEG-MAL,Mw 2k |
| SCPP-202367 | 整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-氨基,分子量5k | RGD-PEG-NH2,Mw 5k |
| SCPP-202366 | 整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-氨基,分子量3.4k | RGD-PEG-NH2,Mw 3.4k |
| SCPP-202365 | 整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-氨基,分子量2k | RGD-PEG-NH2,Mw 2k |
| SCPP-201339 | 整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-活性酯,分子量5k | RGD-PEG-NHS,Mw 5k |
| SCPP-201338 | 整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-活性酯,分子量3.4k | RGD-PEG-NHS,Mw 3.4k |
| SCPP-201337 | 整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-活性酯,分子量2k | RGD-PEG-NHS,Mw 2k |
上海赛可锐生物是一家专业的实验室产品供应商。公司可提供超百万种的各类化学标准品,杂质对照品,化学试剂,生物试剂等科研用品,包括2H(氘代)、13C、15N、17O和18O等同位素产品,产品种类齐全,包括:无机物、有机物、糖类、脂肪酸、氨基酸、维生素、胆汁酸、儿茶酚胺、类固醇、药物中间体标品及其系列同位素产品。主要客户广泛分布于制药、食品、政府机构、第三方检测机构、化工、科研、临床等行业。公司目前已与国内外众多品牌建立了稳定的业务往来,代理百余种国内外知名品牌。
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
技术资料暂无技术资料 索取技术资料
RGD PEG系列
询价









